Insights

Innovative Product Portfolio POZEN has a proven track record of developing novel pharmacologic agents and securing FDA approval for self-invented products. Their focus on integrated therapies aimed at unmet medical needs presents an opportunity to promote complementary or adjunctive products to healthcare providers seeking innovative solutions.

Emphasis on Cost-Effective Therapies The company's development of evidence-based, affordable medicines such as aspirin therapies indicates a strong positioning in the value-driven pharmaceutical market. Sales strategies can highlight their commitment to affordability and efficacy to appeal to payers and providers prioritizing cost savings.

Growing Industry Focus As a specialty pharmaceutical company targeting unmet needs, POZEN operates in a niche that is increasingly attractive due to demographic trends and rising chronic conditions. Opportunities exist to align sales efforts with emerging medical trends and target specialized healthcare providers.

Strategic Licensing Model POZEN’s history of licensing products to larger pharma companies suggests a readiness for partnership expansion. There is potential to develop joint ventures or licensing agreements for new therapies, expanding market access and sales channels.

Focused Market Position With a compact team and targeted product development, POZEN presents a specialized opportunity—offering tailored sales approaches that emphasize their innovative, evidence-based solutions and their strategic focus on unmet medical needs, appealing to niche healthcare markets seeking efficacy and affordability.

Similar companies to POZEN

POZEN Tech Stack

Media & News

POZEN Inc. to Announce Third Quarter 2015 Results on November 9, 2015
CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN) today announced that the Company plans to release results for the third quarter 2015 on Monday, November 9, 2015, before the opening of the U.S. markets. The Company also will conduct a conference call that day at 11:00 a.m. ET to discuss results and highlights of the third quarter of 2015. The presentation slides to be used during the call will be available on the "Investors" section of the Company's website under the "Overview" tab beginning at 11:00 a.m. ET on Monday, November 9, 2015. A live webcast of the conference call, presentation and question and answer session will be available on the "Investors" section of the Company's website under the "Overview" tab. To access the live webcast, please log on to POZEN's site approximately 15 minutes prior to the presentation to register and download any necessary audio software. The presentation replay will be available for 90 days after the event. Conference call details:Date: Monday, November 9, 2015Time: 11:00 a.m. ETDial-in (U.S.): 877-407-8037Dial-in (International): 201-689-8037Webcast: www.pozen.com About POZEN POZEN Inc. is a specialty pharmaceutical company that to date has historically focused on developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products. Funded by these milestones/royalty streams, POZEN has created a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage. POZEN’s common stock is traded under the symbol “POZN” on The NASDAQ Global Market. For more detailed company information, including copies of this and other press releases, please visit www.pozen.com.
Oct 26, 2015 | www.businesswire.com

POZEN's Email Address Formats

POZEN uses at least 1 format(s):

POZEN Email Formats	Example	Percentage
FLast@pozen.com	JDoe@pozen.com	79%
First.Last@pozen.com	John.Doe@pozen.com	10%
First@pozen.com	John@pozen.com	7%
F.Last@pozen.com	J.Doe@pozen.com	4%

Frequently Asked Questions

Where is POZEN's headquarters located?

POZEN's main headquarters is located at 1414 Raleigh Road Suite 400 Chapel Hill, North Carolina 27517 United States. The company has employees across 2 continents, including North AmericaEurope.

What is POZEN's phone number?

You can contact POZEN's main corporate office by phone at

+1-919-913-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is POZEN's stock symbol?

POZEN is a publicly traded company; the company's stock symbol is POZN.

What is POZEN's official website and social media links?

POZEN's official website is pozen.com and has social profiles on LinkedIn.

What is POZEN's NAICS code?

POZEN's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does POZEN have currently?

As of April 2026, POZEN has approximately 29 employees across 2 continents, including North AmericaEurope. Key team members include Sr. Vp And Cfo: B. H.Evp Product Development: M. R.Senior Director , Marketing: W. S.. Explore POZEN's employee directory with LeadIQ.

What industry does POZEN belong to?

POZEN operates in the Pharmaceutical Manufacturing industry.

What is POZEN's email format?

POZEN's email format typically follows the pattern of FLast@pozen.com. Find more POZEN email formats with LeadIQ.

When was POZEN founded?

POZEN was founded in 1996.

POZEN

Q: What is POZEN's official website and social media links?

POZEN's official website is pozen.com. POZEN has social profiles on LinkedIn.

Q: How many employees does POZEN have currently?

POZEN has approximately 29 employees.

Q: What is POZEN's NAICS code?

POZEN's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees

POZEN Inc., headquartered in Chapel Hill, NC, is a progressive pharmaceutical company committed to transforming medicine that transforms lives. POZEN’s unique in-source business model has been proven through our success in gaining U.S. FDA approval of two self-invented products in two years – something almost no other small pharmaceutical company has achieved. Moving forward, POZEN continues to be dedicated to addressing unmet needs and developing affordable medicines for patients and physicians.

Since our founding in 1996, POZEN has had a long, successful history of creating novel pharmacologic agents by combining existing drug therapies that result in superior patient outcomes. This approach allows for a potentially higher success rate than NCE (new chemical entity) development.

Company Overview

Headquarters: 1414 Raleigh Road Suite 400 Chapel Hill, North Carolina 27517 United States
Phone number: +1-919-913-****
Website: pozen.com
Stock Symbol: POZN
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 1996
Employees: 11-50